Edition: United Kingdom United Kingdom Select Region
Email: Passwd: or sign up free
One News Page
One News Page United Kingdom > Health > BioLineRx patent protection extended for schizophrenia drug
Open news article

BioLineRx patent protection extended for schizophrenia drug

Monday, 24 September 2012

TEL AVIV (Reuters) - Israeli biopharmaceutical development firm BioLineRx received a new patent from the U.S. Patent and Trademark Office for BL-1020, an experimental schizophrenia treatment.
Share on FacebookShare on Twitter Comment

You Might Like

Other recent news in Health

11 DIY tips to keep your feet HAPPY in the summer!U-M analysis: Rural HEALTH CARE options more limited in Michigan
Debbie Gibson battles LYME DISEASE!Finding good BROWN FAT with MRI could help promote weight loss
AstraZeneca CANCER pipeline seen as draw for PfizerMarijuana fans pack 4/20 events in Colorado, WASHINGTON state
EASTER Sunday Dialogue: If your God is dead, try mineArthritis drug stops selling in CANADA; leaves young patients desperate
SAUDI ARABIA reports 3 more deaths from MERS virusSTRENGTH TRAINING gets a makeover from yesteryear's body building



comments powered by Disqus

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2014 One News Page Ltd. All Rights Reserved.  |  About us  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
One News Page - Top Headlines RSS Feed RSS  |  News for my Website  |  Free news search widget  |  Advertise  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |  One News Page on Facebook LIKE us on Facebook  One News Page on Twitter FOLLOW us on Twitter  One News Page on Google+ FIND us on Google+

Bullet: One News Page official news app for iPhone Bullet: Our news app for iPhone